Actively Recruiting
Earlier Detection and Optimization of Treatment and Prognosis for Patients With Early-onset Colorectal Cancer
Led by The Netherlands Cancer Institute · Updated on 2025-08-05
300
Participants Needed
1
Research Sites
722 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study aims to collect high quality clinical data on lifestyle and patient biomaterials prior to start or during / after treatment of early-onset colorectal cancer (EOCRC) and to inform on treatment and survival outcomes of EOCRC patients.
CONDITIONS
Official Title
Earlier Detection and Optimization of Treatment and Prognosis for Patients With Early-onset Colorectal Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with locoregional or metastatic colorectal cancer (CRC)
- Histologically proven CRC
- Age 18 - 49 years at time of first CRC diagnosis
- Able to understand the informed consent form
- Provide written informed consent.
You will not qualify if you...
- Mentally incompetent patients based on the opinion of treating physician
- Inability to understand the Dutch language
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Netherlands Cancer Institute
Amsterdam, North Holland, Netherlands, 1066CX
Actively Recruiting
Research Team
R
Ruud Weijer, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here